[1]
2020. REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY: Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy. Mediterranean Journal of Hematology and Infectious Diseases. 13, 1 (Dec. 2020), e2021012. DOI:https://doi.org/10.4084/mjhid.2021.012.